Manulife (Manufacturers Life Insurance)
LEGN icon

Manulife (Manufacturers Life Insurance)’s Legend Biotech LEGN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299K Sell
10,361
-32
-0.3% -$863 ﹤0.01% 2408
2026
Q1 		$188K Buy
10,393
+570
+6% +$10.9K ﹤0.01% 2480
2025
Q4 		$214K Sell
9,823
-885
-8% -$25.4K ﹤0.01% 2499
2025
Q3 		$349K Sell
10,708
-73,373
-87% -$2.71M ﹤0.01% 2331
2025
Q2 		$2.98M Buy
84,081
+11,771
+16% +$381K ﹤0.01% 1357
2025
Q1 		$2.45M Sell
72,310
-4,483
-6% -$161K ﹤0.01% 1409
2024
Q4 		$2.5M Sell
76,793
-205
-0.3% -$8.49K ﹤0.01% 1473
2024
Q3 		$3.75M Sell
76,998
-9,412
-11% -$501K ﹤0.01% 1333
2024
Q2 		$3.83M Sell
86,410
-466,003
-84% -$21.5M ﹤0.01% 1277
2024
Q1 		$31M Sell
552,413
-56,582
-9% -$3.41M 0.03% 481
2023
Q4 		$36.6M Buy
608,995
+18,525
+3% +$1.17M 0.02% 440
2023
Q3 		$39.7M Sell
590,470
-2,545
-0.4% -$177K 0.02% 382
2023
Q2 		$40.9M Buy
593,015
+63,404
+12% +$4.14M 0.02% 381
2023
Q1 		$25.5M Buy
529,611
+21,022
+4% +$1.03M 0.01% 535
2022
Q4 		$25.4M Buy
508,589
+5,579
+1% +$270K 0.02% 511
2022
Q3 		$20.5M Buy
503,010
+4,728
+0.9% +$222K 0.01% 578
2022
Q2 		$27.4M Buy
498,282
+27,280
+6% +$1.15M 0.02% 486
2022
Q1 		$17.1M Buy
471,002
+221,134
+89% +$8.74M 0.01% 707
2021
Q4 		$12M Sell
249,868
-79,500
-24% -$4.03M 0.01% 857
2021
Q3 		$16.7M Hold
329,368
– – 0.01% 733
2021
Q2 		$13.5M Hold
329,368
– – 0.01% 831
2021
Q1 		$9.56M Buy
+329,368
New +$8.98M 0.01% 978

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s LEGN Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Legend Biotech (LEGN) stake by 0.31% in Q2 2026, selling an estimated $863 and leaving 10,361 shares worth $299K. The position accounts for ﹤0.01% of the portfolio, ranked #2408.

Manulife (Manufacturers Life Insurance) first reported a position in LEGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $40.9M in Q2 2023. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 10,361 shares of Legend Biotech worth $299K as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 32 Legend Biotech shares in Q2 2026, an estimated $863.
  • Legend Biotech made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2408 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Legend Biotech in Q1 2021 and has held it in 22 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Legend Biotech position peaked at $40.9M in Q2 2023.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.